Sanjit S Jolly
Overview
Explore the profile of Sanjit S Jolly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
2834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiong D, Valettas N, Jolly S
JACC Case Rep
. 2025 Mar;
30(5):103175.
PMID: 40054949
This case describes percutaneous coronary intervention of a chronic total occlusion of the right coronary artery at the RV marginal bifurcation that was wire-uncrossable until plaque modification with side branch...
2.
dEntremont M, Jolly S
J Soc Cardiovasc Angiogr Interv
. 2024 Dec;
3(11):102393.
PMID: 39649827
No abstract available.
3.
Jolly S, dEntremont M, Lee S, Mian R, Tyrwhitt J, Kedev S, et al.
N Engl J Med
. 2024 Nov;
392(7):633-642.
PMID: 39555823
Background: Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. Methods: In this multicenter trial with a 2-by-2 factorial...
4.
Jolly S, dEntremont M, Pitt B, Lee S, Mian R, Tyrwhitt J, et al.
N Engl J Med
. 2024 Nov;
392(7):643-652.
PMID: 39555814
Background: Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myocardial infarction is...
5.
Moxham R, dEntremont M, Mir H, Schwalm J, Natarajan M, Jolly S
CJC Open
. 2024 Nov;
6(10):1199-1206.
PMID: 39525334
Background: Prehospital transmission of the 12-lead electrocardiogram (ECG) to the interventional cardiologist has become the standard of care in many ST-elevation myocardial infarction (STEMI) networks but has not been adopted...
6.
Moreno R, Dzavik V, Cairns J, Balasubramanian K, Martinez R, Cantor W, et al.
Coron Artery Dis
. 2024 Nov;
36(2):126-138.
PMID: 39506541
The aim was to know the risk and predictive factors of stent thrombosis (ST) in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) in the...
7.
Fiolet A, Poorthuis M, Opstal T, Amarenco P, Boczar K, Buysschaert I, et al.
EClinicalMedicine
. 2024 Oct;
76:102835.
PMID: 39431112
Background: Guidelines recommend low-dose colchicine for secondary prevention in cardiovascular disease, but uncertainty remains concerning its efficacy for stroke, efficacy in key subgroups and about uncommon but serious safety outcomes....
8.
Moreno R, Jolly S
JACC Cardiovasc Interv
. 2024 Sep;
17(19):2226-2227.
PMID: 39297859
No abstract available.
9.
dEntremont M, Wang B, Tsang M, Jolly S
JACC Cardiovasc Interv
. 2024 Jul;
17(13):1619-1621.
PMID: 38986663
No abstract available.
10.
dEntremont M, Lee S, Mian R, Kedev S, Montalescot G, Cornel J, et al.
Am Heart J
. 2024 Jun;
275:173-182.
PMID: 38936755
Background: Patients experiencing myocardial infarction (MI) remain at high risk of future major adverse cardiovascular events (MACE). While low-dose colchicine and spironolactone have been shown to decrease post-MI MACE, more...